New global trial testing oral therapy for MS spasticity
UC expert featured in MS News Today article
The University of Cincinnati's Shahla Hosseini, MD, PhD, was featured in a Multiple Sclerosis (MS) News Today article discussing a new international clinical trial testing an oral drug that enhances naturally occurring molecules in the body to help muscles relax as a treatment for spasticity in patients with MS.
Many patients with MS experience spasticity, which causes muscles to resist being stretched, leading to pain, impaired function, decreased mobility and poorer quality of life.
“Physicians who treat muscle spasticity have a limited number of medications from which to choose. In the past 20 to 30 years, we haven’t seen development of new effective oral medications to treat spasticity in the United States,” said Hosseini, adjunct associate professor of Physical Medicine and Rehabilitation in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Health physician. “The majority of the currently available oral medications have side effects like drowsiness, which limits their usefulness during the daytime, and so we really need a new effective treatment for spasticity that’s better tolerated by patients.”
The body naturally produces molecules called endocannabinoids that help muscles relax and play a role in other functions, including regulating mood, pain and sleep, Hosseini explained. The trial drug is designed to inhibit two enzymes that break down endocannabinoids, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), allowing the endocannabinoids to help regulate the overly reactive spastic muscles.
Read the MS News Today article.
Featured photo at top of a person with knee stiffness. Photo/PonyWang/iStock Photo.
Related Stories
From the pitch to personal impact
May 11, 2026
Hoxworth Blood Center, University of Cincinnati, is uniting blood donors around one shared mission — saving lives close to home — through two unique blood drives this May. From the FC Cincinnati Blood Drive at TQL Stadium to an event honoring local blood recipient and cancer survivor John Mattingly, these blood drives offer meaningful ways to give back. Whether inspired by hometown pride or a powerful personal story, blood donors are encouraged to roll up their sleeves and help ensure life-saving blood is available for patients across the Tristate. Patients at local hospitals depend on blood donations every day, and community support is critical to maintaining a strong supply.
GE Aerospace workforce training focuses on Dayton workers
May 11, 2026
GE Aerospace is launching more employee training at its Beavercreek Plant. The Dayton Daily News talks to the company's site leader, a University of Cincinnati graduate who got his start at GE Aerospace through UC's co-op program.
UC Blue Ash announces 2026 outstanding alumni award winner
May 11, 2026
Mark Brueggeman has enjoyed a long and successful business career that includes launching his own petrochemical distribution company that has clients around the world and grosses more than $150 million per year.